Metabolic Availability in Older and Younger Men (YOMA)

March 19, 2024 updated by: Marco Mensink, Wageningen University

Metabolic Availability of Three Protein Sources in Older and Younger Men as Measured With the Indicator Amino Acid Oxidation Method

The main goal of this study is to determine the metabolic availability of methionine in black beans, lysine in sorghum and lysine in milk using the indicator amino acid oxidation method both in older and in younger men.

Study Overview

Status

Recruiting

Conditions

Study Type

Interventional

Enrollment (Estimated)

28

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Gelderland
      • Wageningen, Gelderland, Netherlands, 6708PB
        • Recruiting
        • Wageningen University & Research
        • Contact:
          • Fenna Hinssen, MSc
          • Phone Number: +031648043165
          • Email: yoma@wur.nl
        • Contact:
          • Karen Fransen, MSc
          • Phone Number: +031648043165
          • Email: yoma@wur.nl

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

Gender: Male Age: 20-35 years or 65-80 years Body Mass Index (BMI): 18.5 - 30.0 kg/m2 Healthy as assessed with a questionnaire Regular and normal eating habits as assessed with a Food Frequency Questionnaire (FFQ) Willing to comply with study procedures and use of data Having given written informed consent

Exclusion Criteria:

Chronic disease, for example:

  • Diabetes mellitus / being treated for high blood glucose
  • Severe cardiovascular disease (exception: hypertension)
  • Hepatic disease (e.g. hepatitis)
  • Renal disease
  • Cancer
  • Bowel disease (e.g. inflammatory bowel disease, ulcers, bleeding)
  • Pancreatitis

History of medical or surgical events that may affect GI function, and the study outcomes or disease risk for participants, for example:

  • Bariatric surgery
  • Gastrointestinal tract surgery
  • Digestive tract disorder
  • Chewing problems
  • History of deep venous thrombosis without anti-coagulation medication

Medicine use that interferes with, protein metabolism, GI function and the study outcomes, for example:

  • Glucose lowering drugs
  • Proton pump inhibitors
  • Laxatives

Habits that interfere with the study outcomes:

  • Protein supplement use (current use or less than 2 weeks past use)
  • Smoking
  • Drug use
  • Alcohol consumption >21 units/week and/or >4/day
  • Following a weight-loss diet, medically prescribed diet or other diet with a low calorie intake or an unbalanced nutrient intake like a vegan or very low carbohydrate diet
  • Moderate to high intense physical activity for more than 5 hours a week

Other:

  • Self-reported allergy or intolerance to the tested products
  • Weight loss of more than 3 kg in the 3 months prior to study screening
  • Current participation in other research and <2 months prior participation in other research
  • Not having a general practitioner
  • Not willing to accept information-transfer concerning participation in the study , or information regarding his health to his general practitioner
  • Working or doing an MSc- thesis at the department of Human Nutrition and Health at Wageningen University & Research

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Methionine in black beans in older men
This group of 7 participants will have 3 test days where they consume black beans with 3 different levels of methionine and they will have 4 test days where they consume the reference amino acid mixture with 4 different levels of methionine.
Black beans cooked and mashed and amino acid mixture as liquid drink to make methionine the limiting amino acid in the food consumed
Other Names:
  • Nutrition
Experimental: Methionine in black beans in younger men
This group of 7 participants will have 3 test days where they consume black beans with 3 different levels of methionine and they will have 4 test days where they consume the reference amino acid mixture with 4 different levels of methionine.
Black beans cooked and mashed and amino acid mixture as liquid drink to make methionine the limiting amino acid in the food consumed
Other Names:
  • Nutrition
Experimental: Lysine in milk or sorghum in older men
This group of 7 participants will have 3 test days where they consume milk with 3 different levels of lysine, they will have 3 test days where they consume sorghum with 3 different levels of lysine and they will have 4 test days where they consume the reference amino acid mixture with 4 different levels of lysine.
Skimmed milk as liquid drink and amino acid mixture as liquid drink to make lysine the limiting amino acid in the food consumed
Other Names:
  • Nutrition
Sorghum cooked and mashed and amino acid mixture as liquid drink to make lysine the limiting amino acid in the food consumed
Other Names:
  • Nutrition
Experimental: Lysine milk or sorghum in younger men
This group of 7 participants will have 3 test days where they consume milk with 3 different levels of lysine, they will have 3 test days where they consume sorghum with 3 different levels of lysine and they will have 4 test days where they consume the reference amino acid mixture with 4 different levels of lysine.
Skimmed milk as liquid drink and amino acid mixture as liquid drink to make lysine the limiting amino acid in the food consumed
Other Names:
  • Nutrition
Sorghum cooked and mashed and amino acid mixture as liquid drink to make lysine the limiting amino acid in the food consumed
Other Names:
  • Nutrition

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Metabolic availability of methionine in black beans and lysine in milk and sorghum measured with the indicator amino acid oxidation method.
Time Frame: 1 measurement to be calculated from repeated measurements on several test days separated by 1 week
Indicator amino acid oxidation method is used to measure metabolic availability of the limiting amino acid by measuring the oxidation of the 13C-labelled indicator amino acid in expired breath as 13CO2 when giving different levels of the limiting amino acid. Methionine metabolic availability will be assessed in black beans and lysine metabolic availability in milk and sorghum.
1 measurement to be calculated from repeated measurements on several test days separated by 1 week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 19, 2024

Primary Completion (Estimated)

December 31, 2024

Study Completion (Estimated)

April 1, 2025

Study Registration Dates

First Submitted

December 19, 2023

First Submitted That Met QC Criteria

March 19, 2024

First Posted (Actual)

March 27, 2024

Study Record Updates

Last Update Posted (Actual)

March 27, 2024

Last Update Submitted That Met QC Criteria

March 19, 2024

Last Verified

March 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • NL84684.091.23

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Ageing

Clinical Trials on Black beans

3
Subscribe